Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:disease incidence/prevalence measurement
go back to main search page
Accession:CMO:0000926 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display a disease at a point in time or develop a disease within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
Comment:Epidemiologically, incidence specifically refers to "the rate at which a certain event occurs, as the number of new cases of a specific disease occurring during a certain period in a population at risk" (Dorland), but in popular usage it can also be used as a measure of the number of individuals in a population which have a particular condition, i.e. as a synonym for prevalence.


show annotations for term's descendants           Sort by:
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    disease population measurement 0
      disease incidence/prevalence measurement 0
        alimentary/gastrointestinal disease incidence/prevalence measurement + 0
        arthritis incidence/prevalence measurement + 0
        cataract incidence/prevalence measurement + 0
        chronic pancreatitis incidence/prevalence measurement + 0
        congenital malformation incidence/prevalence measurement + 0
        diabetes mellitus incidence/prevalence measurement + 0
        endometrioid carcinoma incidence/prevalence measurement + 0
        glycosuria incidence/prevalence measurement + 0
        hematuria incidence/prevalence measurement + 0
        infection incidence/prevalence measurement + 0
        leukemia incidence/prevalence measurement + 0
        lymphoma incidence/prevalence measurement + 0
        nervous system disease incidence/prevalence measurement + 0
        organ non-tumorous lesion incidence/prevalence measurement + 0
        organ tumorous lesion incidence/prevalence measurement + 0
        percentage of study population developing ascites during a period of time 0
        percentage of study population developing extra-hepatic metastases during a period of time 0
        percentage of study population developing peritoneal carcinomatosis during a period of time 0
        percentage of study population developing radiation pneumonitis during a period of time 0
        percentage of study population developing radiation-induced bone marrow disease during a period of time 0
        pyometritis incidence/prevalence measurement + 0
        retinopathy incidence/prevalence measurement + 0
paths to the root